HPQ CEO Explains Why the Company Is Now Ready for Commercialization
In this interview, HPQ CEO Bernard Tourillon offers additional insight into the Company’s latest announcement, which expands its commercial leadership team and business development capabilities, and explains why HPQ believes the time has come to shift from technology validation to commercial execution.
While the press release announced new senior commercial appointments and a strategic partnership with Offset Links, the interview explores why management believes this milestone represents much more than adding personnel. According to Tourillon, years of research, product validation, and customer interest have created the foundation needed to begin building a dedicated commercialization engine.
Among the key points discussed:
✅ HPQ believes its battery technologies have reached the maturity required to move beyond research and into active commercial development.
✅ The newly assembled business development team brings decades of international relationships across industrial and defence markets, providing immediate access to prospective customers rather than relying on traditional sales efforts.
✅ The addition of defence expertise strengthens HPQ’s ability to develop energy solutions for applications including drones, embedded electronics, autonomous systems, and next-generation military equipment.
✅ Management explains why experienced commercialization specialists are essential to maximizing shareholder value while allowing HPQ’s technical teams to remain focused on advancing innovation.
Throughout the discussion, Tourillon explains why HPQ intentionally waited until its technologies were commercially validated before expanding its sales organization, emphasizing that the Company believes it is now “ready for prime time.”
By watching the interview, you’ll learn:
• Why management believes HPQ has reached the point where commercial execution becomes the Company’s next priority.
• How the new business development team differs from a traditional sales force by leveraging decades of established industry relationships.
• Why defence-sector expertise is expected to play an important role in future commercialization efforts.
• How HPQ’s exclusive North American commercialization rights position the Company to benefit as Novacium expands internationally.
• Why management believes building the right commercial organization today will help maximize long-term shareholder value.
Watch the full interview here:
Your continued support is vital in driving our mission forward, and we remain dedicated to keeping you informed about our ongoing projects and achievements.
